Monica Calkins

Dr. Calkins is Professor of Psychology in Psychiatry at the University of Pennsylvania Perelman School of Medicine. Her research program focuses on the clinical characterization and treatment of psychopathology, especially psychotic disorders, and the evaluation of biobehavioral measures of psychosis risk. The overarching goal of this collaborative research program is to contribute to enhanced early identification of psychosis and increased understanding of its pathophysiological processes. Dr. Calkins is Co-Director of the Pennsylvania Early Intervention Center/HeadsUp, which provides ongoing education, training and outreach support for Pennsylvania First Episode Psychosis programs and other stakeholder groups. As the Director of Clinical Research Assessment in the Neurodevelopment and Psychosis Section, Dr. Calkins has led the conceptualization of assessment approaches, development, adaptation and implementation of instruments, training and supervision of assessors, quality control procedures, and use and interpretation of clinical data across numerous NIMH funded grants. Drawing from these experiences, she has participated with global leaders in think tanks aiming to enhance clinical characterization of the psychosis spectrum, playing a role in determining the field’s definitions of clinical high risk constructs. Locally, she is the Associate Director of the Penn Psychosis Evaluation and Recovery Center (PERC). She has delivered many local, national and international lectures on topics including biobehavioral risk factors for psychosis, early identification of psychosis, psychopathology assessment, careers in psychology, and research ethics. Dr. Calkins involves and mentors students (undergraduate, graduate, medical, resident, post-doctoral) and research coordinators in research design, data collection, data analysis, and manuscript and thesis preparation, and provides clinical supervision to trainees through PERC. She has received career awards from the International Congress on Schizophrenia Research, the American College of Neuropsychopharmacology, the National Alliance on Mentally Illness, and an NIMH KO8 Mentored Clinical Scientist Award. Dr. Calkins has authored more than 200 publications in peer-reviewed journals. She is a member of the University of Pennsylvania Institutional Review Board, and has served as an ad-hoc reviewer for NIMH, several international grant review panels, and for more than 30 journals. ***Professor Monica Calkins will not be considering new graduate students for admission for Fall 2026.***

Kohler CG, Wolf DH, Abi-Dargham A, Anticevic A, Cho YT, Fonteneau C, Gil R, Girgis RR, Gray DL, Grinband J, Javitch J, Kantrowitz JT, Krystal JH, Lieberman JA, Murray JD, Ranganathan M, Santamauro N, Van Snellenberg JX, Tamayo Z, TRANSCENDS Group, Gur RC, Gur RE, Calkins ME: Illness Phase as a Key Assessment and Intervention Window for Psychosis. Biological Psychiatry 3: 340-350, Jun 2023 Notes: In Press. Addington J, Woods SW, Yung AR, Calkins ME, Fusar-Poli P.: Harmonizing the structured interview for psychosis-risk syndromes (SIPS) and the comprehensive assessment of at-risk mental states (CAARMS): An initial approach. Early Interv Psychiatry Jan 2023.